Mutations in MECP2, encoding methyl CpG-binding protein 2, cause Rett syndrome, the most severe autism spectrum disorder. Re-expressing Mecp2 in symptomatic Mecp2-null mice markedly improves function and longevity, providing hope that therapeutic intervention is possible in humans. To identify pathways in disease pathology for therapeutic intervention, we carried out a dominant N-ethyl-N-nitrosourea (ENU) mutagenesis suppressor screen in Mecp2-null mice and isolated five suppressors that ameliorate the symptoms of Mecp2 loss. We show that a stop codon mutation in Sqle, encoding squalene epoxidase, a rate-limiting enzyme in cholesterol biosynthesis, underlies suppression in one line. Subsequently, we also show that lipid metabolism is perturbed in the brains and livers of Mecp2-null male mice. Consistently, statin drugs improve systemic perturbations of lipid metabolism, alleviate motor symptoms and confer increased longevity in Mecp2 mutant mice. Our genetic screen therefore points to cholesterol homeostasis as a potential target for the treatment of patients with Rett syndrome.
At a glance
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG–binding protein 2. Nat. Genet. 23, 185–188 (1999). et al.
- Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Natl. Rev. Genet. 7, 415–426 (2006). &
- A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322–326 (2001). , , , &
- Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr. Opin. Neurobiol. 21, 827–833 (2011). &
- Role of MeCP2, DNA methylation, and HDACs in regulating synapse function. J. Neurodev. Disord. 3, 250–256 (2011). , &
- Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143–1147 (2007). , , , &
- Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679–2689 (2004). et al.
- MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229 (2008). et al.
- A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell 12, 425–435 (2003). , , , &
- The art and design of genetic screens: Drosophila melanogaster. Nature Rev. Genet. 3, 176–188 (2002).
- Suppressor screen in Mpl−/− mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl. Acad. Sci. USA 101, 6553–6558 (2004). et al.
- A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum. Mol. Genet. 17, 2118–2131 (2008). et al.
- Technical approaches for mouse models of human disease. Dis. Model. Mech. 4, 305–310 (2011). , &
- Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105–109 (2012). et al.
- Efficient localization of mutations by interval haplotype analysis. Mamm. Genome 9, 150–154 (1998). &
- Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse. Genome Res. 16, 436–440 (2006). et al.
- Mutation discovery in mice by whole exome sequencing. Genome Biol. 12, R86 (2011). et al.
- Sources of cholesterol during development of the rat fetus and fetal organs. J. Lipid Res. 38, 723–733 (1997). , &
- The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178–201 (2008).
- Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 13, 260–273 (2011). , , &
- 2,3-oxidosqualene, an intermediate in the biological synthesis of sterols from squalene. J. Am. Chem. Soc. 88, 4750–4751 (1966). , &
- Studies on squalene epoxidase of rat liver. J. Biol. Chem. 245, 1670–1674 (1970). &
- Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc. Natl. Acad. Sci. USA 98, 2244–2249 (2001). et al.
- Squalene epoxidase and oxidosqualene lanosterol-cyclase activities in cholesterogenic and non-cholesterogenic tissues. Biochim. Biophys. Acta 487, 204–211 (1977). , , &
- Mechanisms and functions of Hedgehog signalling across the metazoa. Natl. Rev. Genet. 12, 393–406 (2011). , &
- Analysis of the Arabidopsis dry2/sqe1-5 mutant suggests a role for sterols in signaling. Plant Signal. Behav. 4, 873–874 (2009). &
- Identification of the Arabidopsis dry2/sqe1-5 mutant reveals a central role for sterols in drought tolerance and regulation of reactive oxygen species. Plant J. 59, 63–76 (2009). et al.
- Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109, 125–134 (2009). , &
- Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34, 1637–1659 (1993). , &
- Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 390, 287–293 (2009).
- Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 78, 1017–1040 (2009). , , , &
- Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327–331 (2001). , , &
- Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50, 357–371 (2011). &
- Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44, 1780–1789 (2003). , , , &
- Cholesterol-mediated neurite outgrowth is differently regulated between cortical and hippocampal neurons. J. Biol. Chem. 280, 42759–42765 (2005). et al.
- Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness. Am. J. Physiol. 276, G1117–G1124 (1999). , &
- Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 109, III50–III57 (2004). , &
- Specific considerations on the prescription and therapeutic interchange of statins. Farm. Hosp. 36, 97–108 (2012). , , , &
- Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 77, 243–250 (2013). et al.
- Therapeutics for childhood neurofibromatosis type 1 and type 2. Curr. Treat. Options Neurol. 13, 529–543 (2011). &
- Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14α-demethylase (Cyp51) resembles Antley-Bixler syndrome. J. Biol. Chem. 286, 29086–29097 (2011). et al.
- Defects of cholesterol biosynthesis. FEBS Lett. 580, 5442–5449 (2006).
- Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 396, 46–49 (2010). &
- Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980–22988 (2003). et al.
- A role for glia in the progression of Rett's syndrome. Nature 475, 497–500 (2011). et al.
- Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis. Model. Mech. 5, 746–755 (2012).
- Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011). et al.
- Statins and their influence on brain cholesterol. J. Clin. Lipidol. 5, 373–379 (2011).
- Diet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress. J. Neurochem. 118, 611–615 (2011). , , , &
- Steatohepatitis: a tale of two “hits?”. Gastroenterology 114, 842–845 (1998). &
- Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59, 947–958 (2008). et al.
- Rett syndrome: exploring the autism link. Arch. Neurol. 68, 985–989 (2011).
- Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT transcriptional co-repressor. Nat. Neurosci. 16, 898–902 (2013). et al.
- Activity-dependent phosphorylation of MECP2 threonine 308 regulates interaction with NcoR. Nature published online; doi:10.1038/nature12348 (16 June 2013). et al.
- Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27, 1017–1028 (2008). et al.
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934–942 (2012). et al.
- A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315–1319 (2011). et al.
- Functional genetic analysis of mouse chromosome 11. Nature 425, 81–86 (2003). et al.
- A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J. Lipid Res. 53, 1399–1409 (2012). , , &
- Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC(T) method. Methods 25, 402–408 (2001). &
- Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010). &
- The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009). et al.
- R/qtl: QTL mapping in experimental crosses. Bioinformatics 19, 889–890 (2003). , , &
- Video 1: Statin treatment improves home cage activity (101.8 MB, Download)
- 30 second videos of mice treated with lovastatin and vehicle at P56 showing an increase in home cage activity in statin treated Mecp2tm1.1Bird/Y mice immediately following removal of the cage lid.
- Supplementary Text and Figures (6,957.7 KB)
Supplementary figures 1-10 and supplementary tables 1-5